These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12880963)

  • 21. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
    Mrózek K; Heinonen K; Theil KS; Bloomfield CD
    Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors.
    Berbegall AP; Villamón E; Piqueras M; Tadeo I; Djos A; Ambros PF; Martinsson T; Ambros IM; Cañete A; Castel V; Navarro S; Noguera R
    Oncogene; 2016 Mar; 35(11):1423-32. PubMed ID: 26119945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
    Morowitz M; Shusterman S; Mosse Y; Hii G; Winter CL; Khazi D; Wang Q; King R; Maris JM
    Mod Pathol; 2003 Dec; 16(12):1248-56. PubMed ID: 14681326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization.
    Iehara T; Hamazaki M; Sawada T
    Cancer Lett; 2002 Apr; 178(1):83-9. PubMed ID: 11849745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group.
    Lastowska M; Cotterill S; Pearson AD; Roberts P; McGuckin A; Lewis I; Bown N
    Eur J Cancer; 1997 Sep; 33(10):1627-33. PubMed ID: 9389925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.
    Savelyeva L; Corvi R; Schwab M
    Am J Hum Genet; 1994 Aug; 55(2):334-40. PubMed ID: 8037210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events?
    Trakhtenbrot L; Cohen N; Betts DR; Niggli FK; Amariglio N; Brok-Simoni F; Rechavi G; Meitar D
    Cancer Genet Cytogenet; 2002 Sep; 137(2):95-101. PubMed ID: 12393279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
    Hilgenfeld E; Padilla-Nash H; McNeil N; Knutsen T; Montagna C; Tchinda J; Horst J; Ludwig WD; Serve H; Büchner T; Berdel WE; Schröck E; Ried T
    Br J Haematol; 2001 May; 113(2):305-17. PubMed ID: 11380393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population.
    Lim H; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
    J Korean Med Sci; 2020 Apr; 35(14):e82. PubMed ID: 32281311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
    Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
    Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cytogenetic characterization of two non-MYCN amplified neuroblastoma cell lines with complex t(11;17).
    McConville CM; Dyer S; Rees SA; Luttikhuis ME; McMullan DJ; Vickers SJ; Ramani P; Redfern D; Morland BJ
    Cancer Genet Cytogenet; 2001 Oct; 130(2):133-40. PubMed ID: 11675134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization.
    Breen CJ; O'Meara A; McDermott M; Mullarkey M; Stallings RL
    Cancer Genet Cytogenet; 2000 Jul; 120(1):44-9. PubMed ID: 10913676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of karyotypic events and evolution in neuroblastoma.
    Betts DR; Cohen N; Leibundgut KE; Kühne T; Caflisch U; Greiner J; Traktenbrot L; Niggli FK
    Pediatr Blood Cancer; 2005 Feb; 44(2):147-57. PubMed ID: 15390360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
    Cunsolo CL; Bicocchi MP; Petti AR; Tonini GP
    Br J Cancer; 2000 Nov; 83(10):1295-300. PubMed ID: 11044353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genomic profile in high risk neuroblastoma by comparative genomic hybridization].
    Noguera Salvá R; Piqueras Franco M; Ruiz Saurí A; Llombart-Bosch A; Castel Sánchez V; Navarro Fos S
    An Pediatr (Barc); 2006 May; 64(5):449-56. PubMed ID: 16756886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Combaret V; Derré J; Couturier J; Aurias A; Delattre O
    Cancer Genet Cytogenet; 2003 Feb; 141(1):32-42. PubMed ID: 12581896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
    Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
    Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas.
    Tomioka N; Kobayashi H; Kageyama H; Ohira M; Nakamura Y; Sasaki F; Todo S; Nakagawara A; Kaneko Y
    Genes Chromosomes Cancer; 2003 Feb; 36(2):139-50. PubMed ID: 12508242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
    McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
    Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.